FindTrial
Sign In

Is There is a Role of Prophylactic Therapy With Tamsulosin Before Extracorporeal Shock Wave Lithotripsy to Avoid Development of Steinstrasse ?

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00489723
Enrollment
Unknown
Registered
2007-06-21
Start date
2007-05-31
Completion date
Unknown
Last updated
2007-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Stones

Keywords

size of stone 1-2 cm, Pt. with no use of alfa bloker prior ESWL, Pt. without internal stent

Brief summary

The purpose of this study is to determine if there is a role of prophylactic therapy with tamsulosin prior extracorporeal shock wave lithotripsy to avoid development of steinstrasse. 150 persons that will go to Extracorporeal shock wave lithotripsy will randomize to 2 groups. Group 1 -of 75 persons will recieve tamsulosin 0.4 mg x 1/d 2 days before the lithotripsy . Group 2 - of 75 persons will not recieve tamsulosin. 48 hour after the ESWL all 2 group will take abdominal radiograph to evaluate the presence of steinstrasse.

Interventions

DRUGtamsulosin 0.4mg

Sponsors

HaEmek Medical Center, Israel
Lead SponsorOTHER

Study design

Observational model
DEFINED_POPULATION
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
15 Years to 85 Years

Inclusion criteria

* size of stone 1-2 cm

Exclusion criteria

* ureteral stricture Presence of internal stent prior use of alfa bloker prior ESWL

Countries

Israel

Contacts

Primary ContactDORON PEREZ, M.D.
perez_do@clalit.org.il+972-4-6495115

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026